Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

NHS: Drugs

Department of Health written question – answered on 16th February 2017.

Alert me about debates like this

Photo of Baroness Tonge Baroness Tonge Independent Liberal Democrat

To ask Her Majesty’s Government what was the total cost to the NHS of purchasing generic drugs from the Israeli pharmaceutical company Teva in the last financial year.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary of State for Health, Lord in Waiting (HM Household) (Whip)

Information on the cost of generic drugs supplied by Teva is not collected centrally but supplies from Israeli company Teva represent a significant and important part of National Health Service medicines provision. We estimate that the total reimbursement cost of these medicines dispensed in the community may be in the region of £0.5 billion. This does not take account of the margin that pharmacies earn on the medicines they dispense. This margin is subsequently taken into account as contributing towards the target level of funding for community pharmacy as part of the community pharmacy contractual framework.

Israel plays an important role in helping supply medicines for the NHS. Some 100 million prescription items for medicines used in the community in England are estimated to come from companies based in Israel. Teva also funds clinical development in the United Kingdom, including research into dementia.

Does this answer the above question?

Yes3 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.